BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8360884)

  • 1. Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules.
    Waller CL; Marshall GR
    J Med Chem; 1993 Aug; 36(16):2390-403. PubMed ID: 8360884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
    Waller CL; Oprea TI; Giolitti A; Marshall GR
    J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
    Opera TI; Waller CL; Marshall GR
    Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein.
    Gohlke H; Klebe G
    J Med Chem; 2002 Sep; 45(19):4153-70. PubMed ID: 12213058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach to pharmacophore mapping and QSAR analysis using inductive logic programming. Application to thermolysin inhibitors and glycogen phosphorylase B inhibitors.
    Marchand-Geneste N; Watson KA; Alsberg BK; King RD
    J Med Chem; 2002 Jan; 45(2):399-409. PubMed ID: 11784144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.
    Kulkarni SS; Kulkarni VM
    J Med Chem; 1999 Feb; 42(3):373-80. PubMed ID: 9986707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.
    Kharkar PS; Desai B; Gaveria H; Varu B; Loriya R; Naliapara Y; Shah A; Kulkarni VM
    J Med Chem; 2002 Oct; 45(22):4858-67. PubMed ID: 12383011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.
    Klebe G; Abraham U; Mietzner T
    J Med Chem; 1994 Nov; 37(24):4130-46. PubMed ID: 7990113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of predictive 3D-QSAR CoMFA and CoMSIA models for beta-aminohydroxamic acid-derived tumor necrosis factor-alpha converting enzyme inhibitors.
    Murumkar PR; Gupta SD; Zambre VP; Giridhar R; Yadav MR
    Chem Biol Drug Des; 2009 Jan; 73(1):97-107. PubMed ID: 19152638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational procedure for 3D-QSAR analysis using TRNOE experiments and computational methods: application to thermolysin inhibitors.
    Radwan AA; Gouda H; Yamaotsu N; Torigoe H; Hirono S
    Drug Des Discov; 2001; 17(3):265-81. PubMed ID: 11469756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
    Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
    J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors.
    Oprea TI; GarcĂ­a AE
    J Comput Aided Mol Des; 1996 Jun; 10(3):186-200. PubMed ID: 8808736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV-1 protease inhibitors.
    Heidari A; Fatemi MH
    Chem Biol Drug Des; 2017 Jun; 89(6):918-931. PubMed ID: 27933723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thermolysin and neutral endopeptidase 24.11 by a novel glutaramide derivative: X-ray structure determination of the thermolysin-inhibitor complex.
    Holland DR; Barclay PL; Danilewicz JC; Matthews BW; James K
    Biochemistry; 1994 Jan; 33(1):51-6. PubMed ID: 8286362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues.
    Nakagawa Y; Wheelock CE; Morisseau C; Goodrow MH; Hammock BG; Hammock BD
    Bioorg Med Chem; 2000 Nov; 8(11):2663-73. PubMed ID: 11092551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarizability fields for use in three-dimensional quantitative structure-activity relationship (3D-QSAR).
    Bradley M; Waller CL
    J Chem Inf Comput Sci; 2001; 41(5):1301-7. PubMed ID: 11604030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
    Holder S; Lilly M; Brown ML
    Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative molecular field analysis of the antitumor activity of 9H-thioxanthen-9-one derivatives against pancreatic ductal carcinoma 03.
    Horwitz JP; Massova I; Wiese TE; Besler BH; Corbett TH
    J Med Chem; 1994 Mar; 37(6):781-6. PubMed ID: 8145227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.